17.12.2015 • News

Court Says EU Broke Own Rules on Endocrine Disruptors

The EU’s general court in Luxembourg has ruled in favor of Sweden in a long-running dispute with the European Commission over the Scandinavian country’s plans to ban certain chemical compounds suspected of being endocrine disruptors.

In the Dec. 15 ruling, applauded by Sweden, Europe’s second highest court said the EU executive had breached the union’s own law by not making provisions to identify such chemicals in everyday products.

The judges added that Commission had had a “clear, precise and unconditional obligation” to adopt the criteria by December 2013, the agreed date.

An appeal can be brought before Europe’s highest court, the Court of Justice, within two months.

Some of the controversial substances, which include diethylstilbestrol (DES), polychlorinated biphenyls (PCBs), dioxins, perfluoroalkylcompounds, solvents, phthalates, bisphenol A (BPA), organophosphate and organochlorine pesticides, and polybrominated diphenyl ethers (PBDE) are already banned or restricted in some EU countries, including Sweden.

Following a declaration presented to it by public health scientists from around the world in May 2013, the Commission had agreed to establish criteria for identification of endocrine disruptors by the end of that year.

When no action had been taken by May 2014, Sweden’s then-environment minister, Lena Ek, announced plans to sue the Commission, to “force it to deliver the scientific criteria so we can start moving toward a poison-free society.”

Janez Potocnik, at the time EU environment commissioner, said the delays were due to the complexity of the issue, the evolving science and the diverging views among scientists and stakeholders, adding that the Commission was “doing its best to address the issue.”

Sweden, along with European health and environment advocacy groups, has accused EU officials of bowing to pressure from the chemical industry.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.